Viewing Study NCT01526369


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-05-07 @ 7:41 AM
Study NCT ID: NCT01526369
Status: COMPLETED
Last Update Posted: 2025-05-09
First Post: 2012-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Sponsor: Cancer Trials Ireland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-positive metastatic breast cancer. View